17 research outputs found

    Lip reconstruction after major tissue loss

    No full text
    Background: Major defects of the lips are challenging to the reconstructive surgeon. The goals in treating total or near total lip defects are reconstruction of the skin, the muscle, the mucosal lining, maintenance of oral competence and an acceptable cosmetic appearance. Six patients with major lip defects from various causes as seen in our practice were successfully managed are discussed. Case reports: Two patients had major lower lip loss following gunshot injuries, one patient had major upper lip defect following blast injury. Two other patients had post excision defects for lip malignancy while the lasthad a congenital midline defect of the upper lip and primary palate. All patients had lip reconstruction using local flaps, no flap loss was recorded and the postoperative appearance was acceptable to them. Conclusion: Functional and aesthetic outcomes appear acceptable when local flaps are employed in lip reconstruction in this black population even with major lip defects.Key words: lip reconstruction, major lip defect

    The Naso-labial and lateral forehead flaps as a single stage: A case report and review of literature

    No full text
    We present here the case of a patient with a major traumatic nasal loses who had a near-total nasal reconstruction as a single-stage procedure. A 35 year-old civil servant who was involved in a road traffic injury about two years before presentation. He sustained extensive and multiple facial injuries with complete loss of nasal cover and lining. Reconstruction was performed by using superiorly based, bilateral, nasolabial flaps to line the floor and the nasal septum, and a paramedian forehead flap for skin cover. The patient did well postoperatively and was discharged home on the 7 th postoperative day. If the principles concerning cover, support, and lining are adhered to, excellent functional and aesthetic results can be achieved as we have obtained in our patient

    Mycetoma in a 29 Year Old Nigerian: A Case Report

    No full text
    Mycetoma is a chronic granulomatous inflammatory disease caused by either aerophllic actinomycetes or true fungi, eumycetoma. The occurrence is worldwide but it is endemic in some African countries. The disease seems not to be common in our environment. We hereby present a case that was successfully managed in our centre. Mycetoma can cause disfigurement and in advanced cases, deformities and disabilities if not properly managed. Keywords: Mycetoma, granulomatous, fungiNigerian Hospital Practice Vol. 2 (1) 2008: pp. 18-2

    Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.

    No full text
    The current prescription patterns for essential hypertension and the efficacy, safety, tolerability and cost-effectiveness of the newer antihypertensive drugs were evaluated in Nigerian patients. The findings were compared with that of a previous study conducted in the same tertiary hospital 10 years earlier. A cross-sectional evaluation of blood pressure (BP) control in a hypertension clinic was undertaken among 150 Nigerian patients aged 61 +/- 12 years (55% females), with a duration of treatment on a particular drug class or combination of 9 +/- 3 months. The initial blood pressure was 176 +/- 20/108 +/- 11 mmHg and 22% of the patient had concurrent diabetes mellitus. Thiazide diuretics (D) alone or in combination remained the most commonly prescribed drugs in 56% of all patients. There were significant increases in the prescriptions of calcium channel blockers (CCBs) (51%), P < 0.0001, and ACE-inhibitors (ACEIs) (24%), P < 0.0001, but a slight reduction in the use of methyldopa, and fixed drug combinations (P < 0.01) compared to the previous study. The fall in systolic blood pressure on D (r = 0.65, P < 0.001) or CCB (r = 0.48, P < 0.02) was significantly correlated with the initial systolic blood pressure, but not age. More patients achieved normotension BP < 140/90 mmHg on CCB monotherapy (71%), than D monotherapy (56%). Combination therapy with ACEIs + D or methyldopa+thiazides normalized BP in 63 and 68%, respectively. Pulse pressure, a surrogate marker for cardiovascular complications and mortality in essential hypertension, was significantly reduced (P < 0.01) equally by all treatments, with 95% confidence intervals ranging from -28 to -1 mmHg. However, hypertensive-diabetic (HT-DM) patients (n = 33) exhibited no significant change in pulse pressure in response to treatment. Adverse drug reactions that occurred in 11% were impotence or postural dizziness with D, headache and pitting oedema with CCB, and dry cough with ACEI. Pharmaco-economic comparison of the drug classes revealed that for every US dollar (dollar) spent per month, the percentage of treated patients attaining normotension was 18.6 for D, 4.73 for CCB, 3.5 for ACEI + D and 13.6 for methyldopa + thiazides. A combination of ACEI + CCB or D was the preferred treatment for hypertensive-diabetic Nigerians, but only 24% attained a BP < 130/85 mmHg. These results demonstrate a shift in trend to a more rational and efficacious treatment of hypertension over a 10 year period. This may be associated, at least in part, with the intensive and continuous education of the prescribers in rational drug use and the introduction of a hospital formulary. Methyldopa is still a highly efficacious and cost-effective drug in this population. Black HT-DM Africans still constitute a subgroup who not only require more and costlier antihypertensive drugs, but whose BP control is suboptimal, and exhibit a poor therapeutic response to other risk factors (pulse pressure) that constitute a continuing risk for cardiovascular mortality

    Anesthetic and surgical predictors of treatment outcome in re-do craniotomy

    No full text
    Introduction: Craniotomy is a neurosurgical operation done to remove brain tumor, repair vascular lesion, and relieve intracranial pressure. Complications can arise which may necessitate re-do craniotomy. The study is planned to find out the relationship between variables such as age, American Society of Anaesthesiologist (ASA), Glasgow coma score (GCS), frequency of re-do craniotomy, and surgical outcome of re-do craniotomy. Materials and Methods: This is a retrospective study of all the patients who had re-do craniotomy over a 4-year period. The data that were collected included age, sex, ASA classification, indication for re-do craniotomy, GCS, frequency of re-do craniotomy, postoperative complications, and outcome. Results: Twenty-five patients had indication for re-do craniotomy within the study period. Forty percent were male and 60% were female, and their mean age was 38.56 ± 17.38 years. The indications for re-do craniotomy were removal of residual tumor, evacuation of clot, and cerebrospinal fluid leakage. Seventy-six percent had good outcome, while 24% had poor outcome. Outcome was good for patients who had re-do craniotomy done once, while poor outcome was for patients with second and third craniotomies. Ninety percent of patients with ASA 2 had good outcome, while 9.1% had poor outcome; but 64.3% had good outcome with ASA 3, while 37.7% had poor outcome with a P-value of 0.18. Seventy-five percent had poor outcome in patients with GCS of less than 9, while 25% had good outcome; but 14.3% had poor outcome in patients with GCS above 9, while 85.7% had good outcome with a P-value of 0.031. Conclusions: Increasing frequency of re-do craniotomy and lower GCS were major factors affecting outcome in re-do craniotomy in our center. The outcome of these patients is valuable in the management of other patients with re-do craniotomy in future

    Early experience with the use of prosthetic mesh as fascia replacement in structural abdominal wall reconstruction

    No full text
    Background: Abdominal wall defects occur from various causes and require reconstruction. Autogenous tissue is often insufficient and incisional hernia often results. Prosthetic mesh is a proven substitute to autogenous tissue but reports on its use is uncommon in our practice environment. Aim: The aim is to report our early experience with the use of prosthetic mesh in black patients in our practice environment. Materials and Methods: The summaries of three patients with anterior abdominal wall defects which were managed with the use of a prosthetic mesh are presented as well as their intraoperative and postoperative photographs. One patient had intraperitoneal placement of the mesh and developed no complications. Results: One patient who had bowel resection developed a postoperative enterocutaneous fistula away from the site of the mesh and was managed conservatively. Other patients had no complications. Conclusions: The use of prosthetic mesh is recommended
    corecore